Evidence map›Paper›PMID 39927473›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Hybrid Electro-optical Stimulation Improves Ischemic Brain Damage by Augmenting the Glymphatic System.

Min Jae Kim, Jiman Youn, Hong Ju Lee, Seo-Yeon Lee, Tae-Gyu Kim, Young-Jin Jung, Yong-Il Shin, Byung Tae Choi, Joonsoo Jeong, Hwa Kyoung Shin

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Min Jae KimDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea.ORCID https://orcid.org/0000-0003-2883-3189
Jiman YounDepartment of Information Convergence Engineering, Pusan National University, Yangsan, 50612, Republic of Korea.ORCID https://orcid.org/0009-0004-8220-2040
Hong Ju LeeDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea.ORCID https://orcid.org/0000-0001-8195-5500
Seo-Yeon LeeDepartment of Pharmacology, Wonkwang University School of Medicine, Iksan, 54538, Republic of Korea.ORCID https://orcid.org/0000-0002-2503-1204
Tae-Gyu KimSchool of Healthcare and Biomedical Engineering, Chonnam National University, Yeosu, 59626, Republic of Korea.ORCID https://orcid.org/0009-0005-9305-7827
Young-Jin JungSchool of Healthcare and Biomedical Engineering, Chonnam National University, Yeosu, 59626, Republic of Korea.ORCID https://orcid.org/0000-0003-0169-2865
Yong-Il ShinDepartment of Rehabilitation Medicine, School of Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea.ORCID https://orcid.org/0000-0001-7894-0930
Byung Tae ChoiDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea.ORCID https://orcid.org/0000-0002-5965-4346
Joonsoo JeongDepartment of Information Convergence Engineering, Pusan National University, Yangsan, 50612, Republic of Korea.ORCID https://orcid.org/0000-0003-1541-5586
Hwa Kyoung ShinDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea.ORCID https://orcid.org/0000-0002-8061-6782

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF), Ministry of Education RS-2022-NR071112National Research Foundation of Korea (NRF), Korean government (MSIP) RS-2021-NR056452National Research Foundation of Korea (NRF), Korean government (MSIP) RS-2023-00217893
6 · The paper itself

Abstract

Ischemic brain injury not only results in significant neurological, motor, and cognitive impairment but also contributes to the accumulation of toxic solutes and proinflammatory cytokines in the infarction region, exacerbating ischemic brain damage. The glymphatic system, which is crucial for brain waste clearance and homeostasis, is impaired by ischemic injury, highlighting the importance of developing therapeutic strategies for poststroke complications. Herein, a novel hybrid electro-optical stimulation device is proposed that integrates near-infrared micro-light-emitting diode with transparent microneedles, enabling efficient noninvasive stimulation of the cortical area for ischemic stroke treatment. This study investigates whether this hybrid electro-optical stimulation enhances the glymphatic system function and ameliorates ischemic brain injury in the middle cerebral artery occlusion and reperfusion (MCAO/R) mice model. The results demonstrate that hybrid stimulation improves the neurological, motor, and cognitive functions and reduces brain atrophy following MCAO/R. Moreover, hybrid stimulation restores impaired glymphatic system function by modulation of aquaporin-4 (AQP4) polarization and alleviates the accumulation of proinflammatory cytokines such as IL-1β. Notably, AQP4 inhibition partly reverses the improved functional outcomes of hybrid stimulation. The findings suggest that targeting glymphatic drainage using hybrid electro-optical stimulation is a promising therapeutic approach for treating ischemic brain injury.

Indexed as

Brain IschemiaElectric Stimulation TherapyGlymphatic SystemAnimalsAquaporin 4BrainDisease Models, AnimalInfarction, Middle Cerebral ArteryMaleMiceMice, Inbred C57BLAquaporin 4aquaporin‐4 polarizationcerebrospinal fluidglymphatic systemhybrid electro‐optical stimulationischemic stroke

Identifiers

PMID39927473
PMCPMC11967803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.